NCT01614093View on ClinicalTrials.gov

Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Schizophrenia
Interventions
DRUG

Oxytocin

Single dose intranasal oxytocin (24 IU)

DRUG

Placebo

Placebo- Sugar pill

Trial Locations (1)

21716

Maryland Psychiatric Research Center, Catonsville

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT01614093 - Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia | Biotech Hunter | Biotech Hunter